Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Détails bibliographiques
Auteurs principaux:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Format:	Conference item
Publié:	2011

Documents similaires

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
par: Gillies, R, et autres
Publié: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
par: Gillies, R, et autres
Publié: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
par: Hatch, S, et autres
Publié: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
par: Graf, Nora, et autres
Publié: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
par: MacGregor, T, et autres
Publié: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
par: Hatch, S, et autres
Publié: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
par: T. P. MacGregor, et autres
Publié: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
par: Sharma, R, et autres
Publié: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
par: Gillies, R, et autres
Publié: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
par: Gillies, R, et autres
Publié: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
par: McHugh, PJ
Publié: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
par: Peter J McHugh
Publié: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
par: Mariangela Sabatella, et autres
Publié: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
par: Findlay, J, et autres
Publié: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
par: Yang, J, et autres
Publié: (2010)

Oesophageal and gastro-oesophageal junction tumours
par: Bird-Lieberman, E, et autres
Publié: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
par: Anwaar Ahmad, et autres
Publié: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
par: Findlay, J, et autres
Publié: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
par: den Boer, RB, et autres
Publié: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
par: Ming-Yii Huang, et autres
Publié: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
par: Abdullah, U
Publié: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
par: Shibo Li, et autres
Publié: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
par: Millo, J, et autres
Publié: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
par: Kaina Bernd, et autres
Publié: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
par: Thomas, A, et autres
Publié: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
par: Sile Li, et autres
Publié: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
par: Bhagwat, N, et autres
Publié: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
par: Maryam Faridounnia, et autres
Publié: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
par: Jiajia Wang, et autres
Publié: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
par: Wang, A, et autres
Publié: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
par: Wang, A, et autres
Publié: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
par: A. G. M. T. Powell, et autres
Publié: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
par: Findlay, J, et autres
Publié: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
par: Jing Xue, et autres
Publié: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
par: Xin Zhang, et autres
Publié: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
par: Gillies, R, et autres
Publié: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
par: Rana, M, et autres
Publié: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
par: Matheus Treuk Medeiros de Araújo
Publié: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
par: Mukherjee, S, et autres
Publié: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
par: Gillies, R, et autres
Publié: (2010)